Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Improved Pseudomonas Exotoxin A With Reduced Immunogenicity

  • Read more about Improved Pseudomonas Exotoxin A With Reduced Immunogenicity
Australia
2010292069
Filed on 2010-09-10

Codon Optimized IL-15 and IL-15R Alpha Genes for Expression in Mammalian Cells

  • Read more about Codon Optimized IL-15 and IL-15R Alpha Genes for Expression in Mammalian Cells
Mexico
MX/a/2012/001670
Filed on 2012-02-08

Pharmaceutical Compositions Which Inhibit FKBP52-Mediated Regulation of Androgen Receptor Function And Methods Of Using Same

  • Read more about Pharmaceutical Compositions Which Inhibit FKBP52-Mediated Regulation of Androgen Receptor Function And Methods Of Using Same
US Patent 8,859,207
Filed on 2012-03-14

METHOD OF SELECTING CANCER PATIENTS FOR ANTI-ANGIOGENESIS THERAPY IN COMBINATION WITH CHEMOTHERAPY

  • Read more about METHOD OF SELECTING CANCER PATIENTS FOR ANTI-ANGIOGENESIS THERAPY IN COMBINATION WITH CHEMOTHERAPY
Patent Cooperation Treaty
PCT/US2012/027283
Filed on 2012-03-01

Combination Immunotherapy Compositions And Methods

  • Read more about Combination Immunotherapy Compositions And Methods
US Patent 10,383,924
Filed on 2012-01-12

COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS

  • Read more about COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS
Mexico
MX/A/2011/010977
Filed on 2010-04-16

COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS

  • Read more about COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS
South Korea
10-2011-7027319
Filed on 2010-04-16

COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS

  • Read more about COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS
China
201080026166.0
Filed on 2010-04-16

COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS

  • Read more about COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS
Canada
2759013
Filed on 2010-04-16

METHODS OF TREATING PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH AN ANTI-CD22 IMMUNOTOXIN

  • Read more about METHODS OF TREATING PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH AN ANTI-CD22 IMMUNOTOXIN
US Application 13/207,856
Filed on 2011-08-11

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 749
  • Page 750
  • Page 751
  • Page 752
  • Page 753
  • Page 754
  • Page 755
  • Page 756
  • Page 757
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health